Search Tag: Drug Discovery
2024 25 Aug
The healthcare and life sciences industries are on the cusp of a technological revolution, with artificial intelligence (AI) poised to play a pivotal role in addressing some of the sector's most pressing challenges. The global market for AI in healthcare is projected to reach an astounding $187.95 billion by 2030, reflecting its potential to reshape...Read more
2024 25 Aug
The healthcare and life sciences industries are on the cusp of a technological revolution, with artificial intelligence (AI) poised to play a pivotal role in addressing some of the sector's most pressing challenges. The global market for AI in healthcare is projected to reach an astounding $187.95 billion by 2030, reflecting its potential to reshape...Read more
2024 25 Aug
The healthcare and life sciences industries are on the cusp of a technological revolution, with artificial intelligence (AI) poised to play a pivotal role in addressing some of the sector's most pressing challenges. The global market for AI in healthcare is projected to reach an astounding $187.95 billion by 2030, reflecting its potential to reshape...Read more
2024 12 Aug
Bio X Cell, LLC, a leading producer of monoclonal antibodies for pre-clinical in vivo research applications, is pleased to announce the appointment of Christopher Conway as Chief Executive Officer. Christopher Conway is a seasoned business executive with a 20+ year consistent track record of exceeding goals, developing talent, and change...Read more
2024 09 May
NVIDIA, primarily known for its groundbreaking GPUs in the gaming industry, has made significant strides in healthcare. While its foray into this sector might have initially caused confusion, the company has emerged as a key player, especially in the realm of AI-driven solutions. In recent years, NVIDIA has intensified its efforts, culminating...Read more
2023 30 Oct
This year in 2023, United Imaging has disrupted the molecular imaging industry once again with our innovative technologies. At EANM 2023, we showcased the uMI Panorama™ PET/CT family to the world. The uMI Panorama is breaking barriers in all directions with industry-leading PET image quality, the finest NEMA NU 2-2018 PET spatial resolution at...Read more
2023 29 Mar
Lucy Therapeutics, Inc., a private biotech company developing proprietary mitochondrial-based small molecule therapies and biomarkers for neurological diseases, today announced the appointment of Christopher J. Winrow, Ph.D., a neuroscience and translational medicine expert, as Chief Scientific Officer. For more than 20 years, Dr. Winrow’s career in...Read more